Researchers from the Japan Advanced Institute of Science and Technology, in collaboration with Daiichi Sankyo and the ...

A joint research team led by Professor Eijiro Miyako of the Japan Advanced Institute of Science and Technology (JAIST), in ...

Daichii Sankyo's CFO Koji Ogawa tells CNBC's Squawk Box Asia what the pharma company is doing to mitigate the effects of U.S.

Daiichi Sankyo will hold a virtual conference call for investors on Monday, June 3, 2024 from 6:00 to 7:00 pm CDT / Tuesday, June 4, 2024 from 8:00 to 9:00 am JST.

Every year, April brings the peak bloom period for cherry blossom trees — and one pharma company is tying its involvement with the springtime ritual to its efforts in the oncology space. Japanese ...

Daiichi Sankyo is also collaborating with AstraZeneca for other cancer treatments. One such collaboration is over ADC Enhertu, which is expected to generate over $10 billion in revenue annually.

Daiichi plans to rack up four or five indications over the next few years, making speed, efficiency and synergy more important than ever, Keller said. RELATED: Daiichi Sankyo pulls out of U.S ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Laura McMullin as vice president of the trade group.

Daiichi Sankyo’s five-year business plan (FY2021-2025) is progressing successfully with the rapid and global expansion of its oncology business. In order to ensure the solid achievement of ...

In November 2019, Daiichi Sankyo filed a Declaratory Judgment action in the District Court of Delaware against Seagen in response to communications from Seagen claiming certain intellectual ...

Daiichi Sankyo: PharmaVitae forecasts at a glance 8 Strategic insight 9 Olmesartan franchise central to Daiichi Sankyo's growth over 2002-14 9 Successful prevention of generic threat 9 ...

TOKYO and SAN DIEGO, Sept. 28, 2014 /PRNewswire/ -- Daiichi Sankyo Company, Ltd. (hereinafter Daiichi Sankyo) (TSE:4568) and Ambit Biosciences (AMBI), jointly announced today that they have ...